Cerebrovascular accident

Brainomix AI Reveals Hidden Efficacy of ARG-007 in Severe Stroke Patients

1 month ago talkbio0Tagged ARG-007, Brainomix, Brainomix 360, Cerebrovascular accident, neuroprotective, stroke trial

Brainomix; AI; stroke trial; ARG-007; neuroprotective; Argenica Therapeutics; Brainomix 360 Stroke

Amgen Builds Case for Repatha to Prevent Heart Disease With Landmark Late-Stage Data

4 months ago talkbio0Tagged amgen, Approved, Cardiovascular Diseases, Cardiovascular event, Cerebrovascular accident, LDL-C, Myocardial Infarction, PCSK9 inhibitor, Primary Prevention, Repatha, United States Food and Drug Administration, VESALIUS-CV trial

Amgen; Repatha; VESALIUS-CV trial; primary prevention; cardiovascular disease; PCSK9 inhibitor; LDL-C; FDA approval; major adverse cardiovascular events; heart attack; stroke

Novartis Acquires Anthos Therapeutics for $925M, Regaining Control of Promising Anticoagulant Abelacimab

12 months ago talkbio0Tagged abelacimab, Acquisition, Anthos, Anticoagulants, Atrial Fibrillation, cardiovascular pipeline, Cerebrovascular accident, Factor XI antibody, Novartis

Novartis, Anthos Therapeutics, acquisition, abelacimab, anticoagulant, Factor XI inhibitor, atrial fibrillation, stroke prevention, cardiovascular pipeline

Bayer’s Asundexian Fails to Prevent Strokes, Jeopardizing $5.5 Billion Blockbuster Hopes

1 year ago talkbio0Tagged Asundexian, Atrial Fibrillation, Bayer, Cerebrovascular accident, Clinical Trials, Factor XI inhibitors

Bayer, asundexian, stroke prevention, atrial fibrillation, Factor XI inhibitors, clinical trials